Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced new positive efficacy, safety and ...

A new study in the Journal of Child and Adolescent Psychopharmacology estimates the incidence of neuroleptic malignant ...

Despite the challenges, many individuals with schizophrenia can lead fulfilling lives with the right treatment and support.

Data from the federal government shows that Mississippi consistently ranks in the top five in the nation for its rates of ...

The FDA is poised to issue a decision soon on KarXT, a potential first-in-class antipsychotic for schizophrenia. What should ...

The following is a summary of “Antipsychotic exposure and infection risk in people with schizophrenia spectrum disorders ...

A new nationwide Danish study published in The Lancet Psychiatry found that individuals with schizophrenia spectrum disorders ...

The following search terms were used: ((((cognition OR cognitive OR neurocognitive OR neuropsychological OR neuropsychologic ...

Explore the latest strides in schizophrenia treatment development as 2024 heralds a pivotal year, with promising collaborations and trials.

The use of antipsychotics for schizophrenia was associated with higher risk for severe cases of COVID-19 and non–COVID-19 respiratory infections but not mild infection.

But the healthcare system in the US still struggles to provide adequate care for those with serious mental illness ...

This abated with antipsychotic medication so that she retracted her claims (with ... In any case, a diagnosis of ...